Advertisement

Advertisement

Announcements

Oncology World Mourns the Loss of Jimmie C. Holland, MD, Founder, Field of Psycho-Oncology

The ASCO Post  /  December 26, 2017

Jimmie C. Holland, MD, died suddenly on December 24, 2017, at the age of 89 years. Dr. Holland was the Attending Psychiatrist and Wayne E. Chapman Chair at Memorial Sloan Kettering (MSK) Cancer Center and Professor of Psychiatry, Weill Medical College of Cornell University in New York. Internationa...

Narratives in Oncology

The ASCO Post  /  June 3, 2017 - Narratives Special Issue

Keith Witmer received his Bachelor’s degree in Fine Arts from Otis/Parsons School of Design. He subsequently launched his career in advertising and publication with a commanding presence, initially using pen and ink and scratchboard mediums. Working with clients such as FedEx, pple Computer, Hewle...

ASCO Presidents Through the Years

The ASCO Post  /  June 3, 2017 - Narratives Special Issue

2016–2017 Daniel Hayes, MD 2015–2016 Julie Vose, MD, MBA 2014–2015 Peter Paul Yu, MD, FACP 2013–2014 Clifford A. Hudis, MD, FACP 2012–2013 Sandra M. Swain, MD 2011–2012 Michael P. Link, MD 2010–2011 George W. Sledge, Jr, MD 2009–2010 Douglas W. Blayney, M...

ASCO Honors Leaders in Cancer Care With 2019 Special Awards

The ASCO Post  /  June 3, 2019 - Narratives Special Issue

ASCO and ASCO’s Conquer Cancer Foundation are proud to recognize the winners of ASCO’s Special Awards and Conquer Cancer’s Women Who Conquer Cancer Mentorship Awards and Tribute Award. The recipients of these awards have worked to transform cancer care around the world. Don’t miss the opportunity t...

MD Anderson Cancer Center Marks 75 Years of Research to End Cancer

The ASCO Post  /  December 10, 2016

In November, The University of Texas MD Anderson Cancer Center celebrated its 75th anniversary with a week-long series of events that raised nearly $15 million to support its efforts in patient care and in the investigation and treatment of cancer. Housed on 16 million square feet in the city of Hou...

The US Oncology Network Promotes Marcus Neubauer, MD, to Chief Medical Officer

The ASCO Post  /  August 10, 2018

THE US ONCOLOGY Network recently announced the appointment of Marcus Neubauer, MD, as Chief Medical Officer, building on its mission of delivering a comprehensive approach to cancer care. Michael Seiden, MD, PhD, will continue to lead The US Oncology Network as its President.  Dr. Neubauer has be...

ASH 2017 Outstanding Service and Public Service Awards

The ASCO Post  /  December 10, 2017

The American Society of Hematology (ASH) presented the 2017 awards for outstanding service and public service on December 10 during the 59th Annual Meeting and Exposition in Atlanta. Tom Brokaw is the 2017 recipient of the ASH Outstanding Service Award, presented annually to an individual who h...

First Universal Childhood Cancer Data Lab Opens

The ASCO Post  /  August 25, 2017

ALEX’S LEMONADE STAND FOUNDATION (ALSF) has announced the opening of the first-of-its-kind Childhood Cancer Data Lab (CCDL) with the mission of accelerating cures. ALSF first announced the CCDL at the National Cancer Moonshot Summit in Washington, DC, hosted by former Vice President Joe ...

Clifford A. Hudis, MD, FACP, Named ASCO’s Next CEO

The ASCO Post  /  April 10, 2016

Clifford A. Hudis, MD, FACP, Chief of the Breast Medicine Service, Vice President for Government Relations, and Chief Advocacy Officer at Memorial Sloan Kettering Cancer Center (MSKCC), and Professor of Medicine at Weill Cornell Medical College, has been named the next Chief Executive Officer (C...

Lung Cancer

Lung Cancer Alliance Announces National Framework for Lung Cancer Screening Excellence

The ASCO Post  /  March 1, 2012

The Lung Cancer Alliance (LCA) moved lung cancer screening to a national platform by announcing a Framework for Lung Cancer Screening Excellence, which includes a bill of rights for the at-risk public and guiding principles for lung cancer screening sites. “The science is indisputable: Screening th...

Abstracts From the NCCN 2020 Annual Conference Now Available

The ASCO Post Staff  /  April 10, 2020

Abstracts from posters that would have been presented at the National Comprehensive Cancer Network® (NCCN®) 2020 Annual Conference are now available online. Although NCCN officials were compelled to postpone the conference in response to the coronavirus disease 2019 (COVID-19) pandemic, in order to ...

Richard L. Schilsky, MD, FACP, FSCT, FASCO, Designated a National Associate of the National Academies of Sciences, Engineering, and Medicine

The ASCO Post Staff  /  March 10, 2020

In February 2020, Richard L. Schilsky, MD, FACP, FSCT, FASCO, Chief Medical Officer and Executive Vice President of ASCO, was designated a National Associate of the National Academy of Sciences, Engineering, and Medicine for his decades-long contributions to the National Academy of Medicine (NAM). ...

Barry Paul Sleckman, MD, PhD, to Lead O’Neal Comprehensive Cancer Center

The ASCO Post Staff  /  November 10, 2019

Barry Paul Sleckman, MD, PhD, a well-known cancer researcher who focuses on understanding how DNA double-strand breaks are generated and repaired—a key topic for cancer and immune system development and function—has been named Director of the O’Neal Comprehensive Cancer Center at the University of...

Cleveland Clinic Appoints Jame Abraham, MD, FACP, as Department Chair of Hematology/Medical Oncology

The ASCO Post Staff  /  October 10, 2019

Jame Abraham, MD, FACP, has been appointed the new Chair of the Hematology/Medical Oncology Department at Cleveland Clinic. In this capacity, he will recruit and develop staff as well as guide the department’s focus on patient access and a multidisciplinary approach to care. Dr. Abraham currently ...

Lung Cancer

The Mark Foundation Awards $6 Million Grant for Lung Cancer Research

The ASCO Post  /  September 10, 2019

The Mark Foundation for Cancer Research has awarded a 3-year $6 million grant to support a new phase of discovery for a team of investigators developing, optimizing, and integrating targeted therapies and immunotherapies to improve outcomes for patients with the most common—and most difficult to t...

Rebecca Yang, MD, Joins Atlantic Health System

The ASCO Post  /  August 10, 2018

BREAST SURGEON Rebecca C. Yang, MD, has joined Atlantic Breast Associates at Overlook Medical Center and Carol G. Simon Cancer Center, part of Atlantic Health System Cancer Care, in New Jersey. Dr. Yang is a board-certified general surgeon and fellowship-trained breast surgeon. She joins Atlantic ...

NCCN Hits 1 Million Registered Users Accessing NCCN Guidelines® and Related Content

The ASCO Post  /  November 25, 2017

The National Comprehensive Cancer Network® (NCCN®) has announced that its registration count has grown to more than 1 million users. By registering on the NCCN website, users are able to view and download all of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) free of...

Nobel Prize in Physiology or Medicine: Laureates in Oncology

The ASCO Post  /  June 3, 2017 - Narratives Special Issue

The Nobel Prize in Physiology or Medicine has been awarded to many individuals whose research directly impacted the understanding of cancer: In 2008 to Harald zur Hausen, for his discovery of human papillomavirus causing cervical cancer In 2005 to J. Robin Warren and Barry J. Marshall, for their...

Breast Cancer

Dr. Larry Norton, Honored at 2013 Breast Cancer Symposium, Calls For A Return to the 'Exploration of Concepts'

Caroline Helwick  /  October 15, 2013

Larry Norton, MD, of Memorial Sloan-Kettering Cancer Center, is the recipient of the 2013 Gianni Bonadonna Breast Cancer Award, which he received at the 2013 Breast Cancer Symposium. The Symposium is sponsored by ASCO, the American Society of Breast Surgeons, the American Society of Radiation Oncolo...

NCCN Appoints Dr. Robert Carlson as Chief Executive Officer

The ASCO Post  /  October 15, 2012

The National Comprehensive Cancer Network (NCCN) has appointed Robert W. Carlson, MD, a leading expert in the field of breast medical oncology, as Chief Executive Officer. “Dr. Carlson is highly regarded in the oncology community, and NCCN is extremely pleased to appoint him as CEO. Over the last 1...

Prostate Cancer
Health-Care Policy

Senate Legislation Urges Federal Research Support to Improve Early Detection of Prostate Cancer

The ASCO Post  /  August 15, 2012

U.S. Senator John F. Kerry (D-MA) led unanimous passage of Senate Resolution 493 to recognize prostate cancer as an epidemic striking African American men disproportionately, with 250% higher mortality and 60% higher incidence. This bipartisan legislation urges federal agencies to support research f...

News From the Centers for Medicare & Medicaid Services

The ASCO Post  /  June 3, 2019 - Narratives Special Issue

The Centers for Medicare & Medicaid Services (CMS) recently issued final rulings on several issues relevant to prescription drug prices and Medicaid provider payments. Prescription Drug Prices On May 16, 2019, CMS issued a final rule that modernizes and improves the Medicare Advantage and Par...

ASCO Applauds NCI Announcement on Increased Funding for National Clinical Trials Network

The ASCO Post  /  June 10, 2018

ON JUNE 2, ASCO President Bruce E. Johnson, MD, FASCO, released the following statement:  Today at the 2018 ASCO Annual Meeting, National Cancer Institute (NCI) Director Norman Sharpless, MD, announced $10 million in new funding for the National Clinical Trials Network (NCTN). ASCO applauds Dr. Sha...

NCCN Awards Nine Grants for Quality Improvement in Breast Cancer Care

The ASCO Post  /  February 10, 2018

THE NATIONAL COMPREHENSIVE Cancer Network® (NCCN®) Oncology Research Program in collaboration with Pfizer Global Medical Grants announced they have awarded funding to nine projects that use clinical care pathways to implement quality improvement initiatives along the continuum of care for underserve...

Daniel Von Hoff, MD, FACP, Receives Gold Medal From Columbia University

The ASCO Post  /  June 3, 2017 - Narratives Special Issue

Daniel Von Hoff, MD, FACP—Distinguished Professor, Physician-in-Chief, and Director of Molecular Medicine at the Translational Genomics Research Institute—received a gold medal for excellence in clinical medicine from his alma mater, Columbia University. Columbia University College of Physicians a...

Marc S. Ernstoff, MD, Named UB Chief of Hematology/Oncology, Roswell Park Chair of Medicine

The ASCO Post  /  March 10, 2016

Marc S. Ernstoff, MD, has been appointed Professor and Chief of the Division of Hematology/Oncology in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) and Chair of the Department of Medicine and Senior Vice President of Clinical I...

José Baselga, MD, PhD, Inaugurated as AACR President

The ASCO Post  /  May 10, 2015

The American Association for Cancer Research (AACR) inaugurated José Baselga, MD, PhD, as President for 2015–2016 at the AACR Annual Meeting 2015. Dr. Baselga, an internationally recognized physician-scientist whose research focuses on the clinical development of novel molecularly targeted agents (...

Health-Care Policy

ASCO Commends U.S. House of Representatives for Voting to Repeal the SGR, Urges Senate to Pass Legislation

The ASCO Post  /  April 10, 2015

We applaud the House of Representatives for passing legislation that eliminates the Sustainable Growth Rate [SGR] formula and takes a giant leap toward meaningful and urgently needed Medicare physician payment reform. Cancer incidence among Medicare beneficiaries is expected to increase by 67% by 20...

Survivorship

In Chicago for ASCO? 

The ASCO Post  /  May 15, 2013

Robert H. Lurie Comprehensive Cancer Center of Northwestern University is celebrating the 20th Annual Cancer Survivors’ Celebration with a first!  Join the Lurie Cancer Center for a timed 5K run along the lakefront on Sunday, June 2. The run will start in Chicago’s Grant Park at 7:15 AM, before the ...

Confirmation Hearing for FDA Commissioner Nominee Stephen Hahn, MD

The ASCO Post Staff  /  November 25, 2019

On November 20, 2019, Stephen Hahn, MD, President Trump’s nominee to be the next Commissioner of the U.S. Food and Drug Administration (FDA), appeared before the Senate Health, Education, Labor, and Pension Committee and answered wide-ranging questions relating to the many important roles the Comm...

Head and Neck Cancer

SITC Publishes First Clinical Immunotherapy Guidelines for Treatment of Head/Neck Squamous Cell Carcinoma

The ASCO Post  /  September 10, 2019

The Society for Immunotherapy of Cancer (SITC) has published the first clinical immunotherapy guidelines for squamous cell carcinoma of the head and neck, providing oncologists and other advanced practice providers with a clinical roadmap to treating this disease with immunotherapies approved in the...

Blue Distinction Center for Cellular Immunotherapy Status Granted to Huntsman Cancer Institute

The ASCO Post  /  August 10, 2019

Huntsman Cancer Institute (HCI) at the University of Utah is the first Regence provider designated as a national Blue Distinction Center for Cellular Immunotherapy. Chimeric antigen receptor (CAR) T-cell therapy (CAR–T)-designated hospitals must be certified by a Risk Evaluation and Mitigation S...

Rishi Jain, MD, MS, DABOM, Joins Fox Chase GI Program

The ASCO Post  /  December 25, 2018

Rishi Jain, MD, MS, DABOM, has joined Fox Chase Cancer Center as Assistant Professor in the Gastrointestinal (GI) Medical Oncology Program. After graduating from Fox Chase/Temple University Fellowship Training Program, Dr. Jain moved on to the Gastrointestinal Medical Oncology Program at The Ohio...

Vamsidhar Velcheti, MD, Joins NYU Langone as Director of Thoracic Medical Oncology

The ASCO Post  /  October 10, 2018

Clinician and researcher Vamsidhar ‘Vamsi’ Velcheti, MD, recently joined the Perlmutter Cancer Center at New York University (NYU) Langone Health as Director of Thoracic Medical Oncology. He aims to improve clinical care, increase translational and clinical research, and promote interdisciplinary ...

Hidayatullah G. Munshi, MD, Named Program Leader of Tumor Environment and Metastasis Program at Robert H. Lurie Comprehensive Cancer Center

The ASCO Post  /  March 10, 2016

Hidayatullah G. Munshi, MD, has been named Leader of the Tumor Environment and Metastasis (TEAM) Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The TEAM Program utilizes an integrative approach to elucidate key molecular interactions between tumor cells and c...

ASTRO to Host Virtual Annual Meeting, October 25–28, 2020

The ASCO Post Staff  /  July 25, 2020

The American Society for Radiation Oncology (ASTRO) has announced it will hold its 62nd Annual Meeting October 25–28, 2020, via an interactive virtual platform. The meeting, “Global Oncology: Radiation Therapy in a Changing World,” will feature reports from the latest clinical trials; panels on glob...

ASCO20 Virtual Scientific Program Convened Record Number of Oncology Professionals From Across the Globe

The ASCO Post Staff  /  June 25, 2020

ASCO announced record-breaking attendance at its 3-day ASCO20 Virtual Scientific Program, held online from May 29 through May 31. More than 42,700 attendees from 138 countries have participated thus far, learning virtually about new clinical cancer advances in every area of cancer research. Through...

Role of Physical Activity in Cancer Treatment and Survivorship

The ASCO Post Staff  /  November 25, 2019

On October 16, 2019, an expert panel convened by the American College of Sports Medicine (ACSM)released updated guidance and recommendations on the role of physical activity and exercise in cancer prevention and survivorship. The panel was co-chaired by Kathryn Schmitz, PhD, MPH, of the Department o...

ASTRO and ACR Update Practice Parameters for Radiation Therapies

The ASCO Post Staff  /  November 10, 2019

The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) recently released seven updated practice parameters for medical providers who use radiation therapy to treat patients with cancer. The updated practice parameters synthesize the clinical best practices th...

CDC Foundation Launches Virtual Tool to Prevent Infections in Patients With Cancer

The ASCO Post  /  December 25, 2018

The Centers for Disease Control and Prevention (CDC) Foundation recently launched an educational tool using virtual human technology to improve patient-provider conversations about neutropenia as a side effect of chemotherapy. This new resource is part of the Preventing Infections in Cancer Patients...

AACR Announces 2018 Special Recognition Awards

The ASCO Post  /  May 10, 2018

THE AMERICAN ASSOCIATION for Cancer Research (AACR) presented Special Recognition Awards to the following four individuals whose work has made extraordinary contributions to the AACR’s mission to accelerate the prevention and cure of all cancers through research, education, communication, and collab...

Seattle Children’s Hospital Opens CAR T-Cell Immunotherapy Trial in Pediatric Leukemia

The ASCO Post  /  December 10, 2017

Seattle Children’s Hospital has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the United States for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia (ALL). With this more robust defense, researchers hope the n...

Jeffrey Fowler, MD, Begins Presidency of Society of Gynecologic Oncology

The ASCO Post  /  April 10, 2016

Jeffrey Fowler, MD, John G. Boutselis Chair in Gynecologic Oncology and Professor and Vice-Chair of Obstetrics and Gynecology at The Ohio State University Wexner Medical Center, started his 1-year term as the 48th President of the Society of Gynecologic Oncology (SGO) at the conclusion of the Soci...

Mylin A. Torres, MD, Named Director of Winship’s Glenn Family Breast Center

The ASCO Post  /  March 10, 2016

Winship Cancer Institute of Emory University has named Mylin A. Torres, MD, the new Director of the Glenn Family Breast Center, effective January 19, 2016. She succeeds Ruth O’Regan, MD, who now heads the University of Wisconsin Division of Hematology and Oncology. Dr. Torres is Associate Professor...

U-M Cancer Center Names Bhramar Mukherjee, PhD, Associate Director for Population Science Research

The ASCO Post  /  December 10, 2015

The University of Michigan (U-M) Comprehensive Cancer Center has appointed Bhramar Mukherjee, PhD, as Associate Director for Population Science Research. Dr. Mukherjee is John D. Kalbfleisch Collegiate Professor of Biostatistics and Professor of Epidemiology at the U-M School of Public Health. She ...

Antoni Ribas, MD, PhD, Receives NCI Outstanding Investigator Award

The ASCO Post  /  November 25, 2015

UCLA Jonsson Comprehensive Cancer Center member ­Antoni Ribas, MD, PhD, has received a National Cancer Institute (NCI) Outstanding Investigator Award of $4.2 million in recognition of his research conducted in the development of new immunotherapies that utilize the human body’s own natural defenses ...

ASH Pairs Hematologists From Developing and Developed Nations for Global Training Program

The ASCO Post  /  December 1, 2014

The American Society of Hematology (ASH) recently announced the 20 hematologists and other medical professionals selected to participate in the 2014 ASH Visitor Training Program. This program provides talented hematologists, scientists, and laboratory staff from developing countries the opportunity ...

Timothy Chan, MD, PhD, Named Director of Cleveland Clinic’s Center for Immunotherapy and Precision Immuno-Oncology

The ASCO Post Staff  /  May 10, 2020

Timothy Chan, MD, PhD, has been appointed Director of the Center for Immunotherapy and Precision Immuno-Oncology at Cleveland Clinic. Dr. Chan will lead the new center to bring together multidisciplinary experts from across the Cleveland Clinic enterprise to advance research and treatment related to...

Ethan Basch, MD, MSc, Receives ACCC Clinical Research Award

The ASCO Post Staff  /  November 25, 2019

The Association of Community Cancer Centers (ACCC) 2019 Clinical Research Award was presented to Ethan Basch, MD, MSc, during the ACCC 36th National Oncology Conference held recently in Orlando, Florida. Dr. Basch is the Director of the Cancer Outcomes Research Program and Professor of Hematology ...

$5 Million Gift to Advance Ovarian Cancer Research

The ASCO Post Staff  /  October 25, 2019

The chairman emeritus of The Estée Lauder Companies has made a $5 million gift to the University of Arizona Cancer Center. The gift from Leonard A. Lauder supports the clinical and translational research of David S. Alberts, MD, an expert in the field of ovarian cancer research and treatment. Dr....

Advertisement

Advertisement



Advertisement